These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2019628)

  • 21. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest.
    Thielmann M; Kottenberg E; Boengler K; Raffelsieper C; Neuhaeuser M; Peters J; Jakob H; Heusch G
    Basic Res Cardiol; 2010 Sep; 105(5):657-64. PubMed ID: 20495811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical trial of blood and crystalloid cardioplegia.
    Fremes SE; Christakis GT; Weisel RD; Mickle DA; Madonik MM; Ivanov J; Harding R; Seawright SJ; Houle S; McLaughlin PR
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):726-41. PubMed ID: 6387286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical and functional effects of creatine phosphate in cardioplegic solution during aortic valve surgery--a clinical study.
    Thorelius J; Thelin S; Ronquist G; Halden E; Hansson HE
    Thorac Cardiovasc Surg; 1992 Feb; 40(1):10-3. PubMed ID: 1631861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxygen requirements of the isolated rat heart during hypothermic cardioplegia. Effect of oxygenation on metabolic and functional recovery after five hours of arrest.
    de Wit L; Coetzee A; Kotze J; Lochner A
    J Thorac Cardiovasc Surg; 1988 Feb; 95(2):310-20. PubMed ID: 3339898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
    Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal intraoperative protection of myocardium distal to coronary stenoses.
    Silverman NA; Schmitt G; Levitsky S; Feinberg H
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):424-31. PubMed ID: 6433111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of myocardial protective effects between GIK solution and St. Thomas solution by use of canine isolated heart-lung preparations].
    Ina H; Yasuda I
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Nov; 37(11):2318-27. PubMed ID: 2693545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of blood, crystalloid and oxygenated crystalloid cardioplegia solutions on myoglobin and creatine kinase release following cardiac surgery.
    Gerrish SP; Goiti JJ; Hunsley JE
    Eur J Cardiothorac Surg; 1988; 2(6):438-41. PubMed ID: 3272252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of alternative cardioplegic techniques.
    Weisel RD; Hoy FB; Baird RJ; Ivanov J; Hilton JD; Burns RJ; Mickle DA; Mickleborough LL; Scully HE; Goldman BS; McLaughlin PR
    J Thorac Cardiovasc Surg; 1983 Jul; 86(1):97-107. PubMed ID: 6602917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of potassium cardioplegia on high-energy phosphate kinetics during circulatory arrest with deep hypothermia in the newborn piglet heart.
    Clark BJ; Woodford EJ; Malec EJ; Norwood CR; Pigott JD; Norwood WI
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):342-9. PubMed ID: 1992245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional, metabolic and ultrastructure evidence for improved myocardial protection during severe ischaemic stress with MBS, a new crystalloid cardioplegic solution.
    Choong YS; Gavin JB
    J Cardiovasc Surg (Torino); 1996 Jun; 37(3):275-84. PubMed ID: 8698764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischemic myocardial protection. Comparison of nonoxygenated crystalloid, oxygenated crystalloid, and oxygenated fluorocarbon cardioplegic solutions.
    Tabayashi K; McKeown PP; Miyamoto M; Luedtke AE; Thomas R; Allen MD; Misbach GA; Ivey TD
    J Thorac Cardiovasc Surg; 1988 Feb; 95(2):239-46. PubMed ID: 3339891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluosol cardioplegia--a method of optimizing aerobic metabolism during arrest.
    Rousou JH; Dobbs WA; Engelman RM
    Circulation; 1982 Aug; 66(2 Pt 2):I55-9. PubMed ID: 7083547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cold blood cardioplegia enriched with potassium-magnesium aspartate during coronary artery bypass grafting.
    Ji B; Liu J; Liu M; Feng Z; Wang G; Lu F; Long C
    J Cardiovasc Surg (Torino); 2006 Dec; 47(6):671-5. PubMed ID: 17043614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic enhancement of myocardial preservation during cardioplegic arrest.
    Rousou JA; Engelman RM; Anisimowicz L; Lemeshow S; Dobbs WA; Breyer RH; Das DK
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):270-6. PubMed ID: 3945094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage--importance of endogenous oxygen free radical scavengers in red blood cells.
    Julia PL; Buckberg GD; Acar C; Partington MT; Sherman MP
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):303-13. PubMed ID: 1992241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of cardioplegia with blood and crystalloid potassium solutions during prolonged aortic cross-clamping.
    Nwaneri NJ; Levitsky S; Silverman NA; Feinberg H
    Surgery; 1983 Nov; 94(5):836-41. PubMed ID: 6635947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of myocardial metabolism with microdialysis after protection with cold blood- or cold crystalloid cardioplegia. A porcine model.
    Runge M; Hughes P; Peter Gøtze J; Petersen RH; Steinbrüchel DA
    Scand Cardiovasc J; 2006 Jun; 40(3):186-93. PubMed ID: 16798667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
    Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
    Greenfield DT; Greenfield LJ; Hess ML
    J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.